Gemfields Group Limited (GML.JO)
ZAc 167.0
(7.74%)
ZAc 167.0
(7.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 262.01 Million | 341.1 Million | 257.7 Million | 34.56 Million | 216.23 Million | 206.09 Million |
| Cost of Revenue | 160.65 Million | 160.85 Million | 112.24 Million | 59.06 Million | 124.68 Million | 123.54 Million |
| Gross Profit | 101.36 Million | 180.24 Million | 145.46 Million | -24.49 Million | 91.55 Million | 82.54 Million |
| Operating Expenses | 83.98 Million | 57.62 Million | 41.28 Million | 29.63 Million | 54.62 Million | 61.73 Million |
| Selling, General and Administrative Expenses | 51.43 Million | 36.72 Million | 23.16 Million | 14.28 Million | 32.58 Million | 36.46 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 32.55 Million | 20.9 Million | 18.12 Million | 15.34 Million | 22.04 Million | 708 Thousand |
| Cost and Expenses | 244.63 Million | 218.48 Million | 153.52 Million | 88.69 Million | 179.3 Million | 185.27 Million |
| Operating Income | 17.38 Million | 116.54 Million | 107.63 Million | -93.4 Million | 40.34 Million | -45.1 Million |
| Interest Expense | 2.35 Million | 2.41 Million | 2.7 Million | 2.99 Million | 4.08 Million | 7.3 Million |
| Income Tax Expense | 19.39 Million | 40.38 Million | 39.46 Million | -5.97 Million | 28.24 Million | 6.48 Million |
| Earnings before Tax | 16.56 Million | 114.65 Million | 104.42 Million | -99.2 Million | 67.37 Million | -53.94 Million |
| Net Income | -10.09 Million | 56.77 Million | 50.73 Million | -93.22 Million | 39.13 Million | -62.21 Million |
| Earnings Per Share Basic | -0.01 | 0.05 | 0.04 | -0.08 | 0.03 | -0.05 |
| Earnings Per Share Diluted | -0.01 | 0.04 | 0.04 | -0.08 | 0.03 | -0.05 |
| Weighted Average Shares Outstanding | 1.2 Billion | 1.24 Billion | 1.16 Billion | 1.16 Billion | 1.26 Billion | 1.31 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.2 Billion | 1.24 Billion | 1.16 Billion | 1.16 Billion | 1.26 Billion | 1.31 Billion |
| Gross Margin | 0.39 | 0.53 | 0.56 | -0.71 | 0.42 | 0.40 |
| EBIT Margin | 0.21 | 0.47 | 0.51 | -1.03 | 0.35 | 0.27 |
| Profit Margin | -0.04 | 0.17 | 0.20 | -2.70 | 0.18 | -0.30 |
| EBITDA | 55.85 Million | 154.74 Million | 134.66 Million | -75.18 Million | 105.62 Million | -16.01 Million |
| Earnings Before Tax Margin | 0.07 | 0.34 | 0.42 | -2.70 | 0.19 | -0.22 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 63.98 Million | 63.98 Million | 262.01 Million | 54.2 Million | 54.2 Million | 76.8 Million |
| Cost of Revenue | 33.92 Million | 33.92 Million | 160.65 Million | 40.71 Million | 40.71 Million | 39.61 Million |
| Gross Profit | 30.05 Million | 30.05 Million | 101.36 Million | 13.48 Million | 13.48 Million | 37.19 Million |
| Operating Expenses | 16.81 Million | 16.81 Million | 53.25 Million | 23.03 Million | 23.14 Million | 19.18 Million |
| Selling, General and Administrative Expenses | 14.66 Million | 14.66 Million | - | 13.22 Million | 13.22 Million | 12.49 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 2.14 Million | 2.14 Million | 505 Thousand | 9.81 Million | - | - |
| Cost and Expenses | 50.74 Million | 50.74 Million | 213.9 Million | 63.75 Million | 63.85 Million | 58.79 Million |
| Operating Income | 13.24 Million | 13.24 Million | 17.38 Million | -9.55 Million | -635.5 Thousand | 24.94 Million |
| Interest Expense | - | - | 2.35 Million | - | - | - |
| Income Tax Expense | 5.21 Million | 5.21 Million | 19.39 Million | 592 Thousand | 592 Thousand | 9.1 Million |
| Earnings before Tax | 12.04 Million | 12.04 Million | 16.56 Million | -9.89 Million | -9.89 Million | 18.17 Million |
| Net Income | 3.67 Million | 3.67 Million | -10.09 Million | -9.97 Million | -9.97 Million | 4.92 Million |
| Earnings Per Share Basic | 0.00 | 0.00 | - | -0.01 | -0.01 | 0.00 |
| Earnings Per Share Diluted | 0.00 | 0.00 | - | -0.01 | -0.01 | 0.00 |
| Weighted Average Shares Outstanding | 1.22 Billion | 1.22 Billion | 1.2 Billion | 1.19 Billion | 1.19 Billion | 1.23 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.16 Billion | 1.16 Billion | 1.2 Billion | 1.19 Billion | 1.19 Billion | 1.21 Billion |
| Gross Margin | 0.47 | 0.47 | 0.39 | 0.25 | 0.25 | 0.48 |
| EBIT Margin | 0.38 | 0.38 | - | 0.07 | 0.07 | 0.47 |
| Profit Margin | 0.06 | 0.06 | -0.04 | -0.18 | -0.18 | 0.06 |
| EBITDA | 24.56 Million | 24.56 Million | - | 3.76 Million | 3.76 Million | 35.77 Million |
| Earnings Before Tax Margin | 0.21 | 0.21 | 0.07 | -0.18 | -0.01 | 0.32 |
2125
1NBA
AXCP
DRMA
6349
JOHNPHARMA